Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference31 articles.
1. Howell RW. The MIRD schema: from organ to cellular dimensions. J Nucl Med. 1994;35:531–3.
2. Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations. Revised. New York: The Society of Nuclear Medicine; 1991.
3. Howell RW, Wessels BW, Loevinger R, Watson EE, Bolch WE, Brill AB, et al. The MIRD perspective 1999. J Nucl Med. 1999;40:3S-10S.
4. Prasad A, Nair R, Bhatavdekar O, Howe A, Salerno D, Sempkowski M, et al. Transport-driven engineering of liposomes for delivery of alpha-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases. Eur J Nucl Med Mol Imaging. 2021. https://doi.org/10.1007/s00259-021-05406-z.
5. Stras S, Holleran T, Howe A, Sofou S. Interstitial release of cisplatin from triggerable liposomes enhances efficacy against triple negative breast cancer solid tumor analogues. Mol Pharm. 2016;13:3224–33. https://doi.org/10.1021/acs.molpharmaceut.6b00439.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献